{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-26-005006","form_type":"8-K","ticker":"PBSV","cik":"0001304161","company_name":"Pharma-Bio Serv, Inc.","filed_at":"2026-05-15T21:02:05+00:00","discovered_at":"2026-05-15T21:04:00.307826+00:00","generated_at":"2026-05-15T21:04:17.880317+00:00","sec_items":["9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Pharma-Bio Serv annual meeting elects Irving Wiesen as Class I director","bullets":["Irving Wiesen elected with 10,208,071 votes for and 195,625 withheld; 2,839,645 broker non-votes.","Ratification of Crowe PR PSC as independent auditor for FY ending Oct 31, 2026: 13,241,794 for, 3 against, 1,544 abstain.","No other proposals or material events disclosed at the May 15, 2026 Annual Meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-26-005006","json":"https://secwatch.observer/filing/0001654954-26-005006.json","markdown":"https://secwatch.observer/filing/0001654954-26-005006.md","text":"https://secwatch.observer/filing/0001654954-26-005006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1304161/000165495426005006/0001654954-26-005006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1304161/000165495426005006/pbsv_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T21:04:17.880317+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}